XML 28 R19.htm IDEA: XBRL DOCUMENT v3.23.1
STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS (Tables)
6 Months Ended
Jun. 30, 2022
Medigap Healthcare Insurance Company [Member]  
Business Acquisition [Line Items]  
SCHEDULE OF ALLOCATION OF PURCHASE PRICE

The preliminary allocation of the purchase price in connection with the acquisition of Medigap was calculated as follows:

 

Description  Fair Value   Weighted Average Useful Life (Years) 
Property, plant and equipment  $20,666    5 
Right-of-use asset   317,787      
Trade names   340,000    15 
Customer relationships   4,550,000    12 
Technology   67,000    3 
Backlog   210,000    1 
Chargeback reserve   (1,484,473)     
Lease liability   (317,787)     
Goodwill   19,199,008    Indefinite 
   $22,902,201      
SCHEDULE OF PRO FORMA INFORMATION RELATED TO ACQUISITION

SCHEDULE OF PRO FORMA INFORMATION RELATED TO ACQUISITION

   June 30,   June 30, 
   2022   2021 
Revenue  $8,809,482   $7,071,329 
Net Income (Loss)  $19,849,175   $(1,796,767)
Earnings (Loss) per common share, basic  $11.25   $2.85)
Earnings (Loss) per common share, diluted  $8.85)  $2.85)
Barra [Member]  
Business Acquisition [Line Items]  
SCHEDULE OF ALLOCATION OF PURCHASE PRICE

The preliminary allocation of the purchase price in connection with the acquisition of Barra was calculated as follows:

 

 

Description  Fair Value   Weighted Average Useful Life (Years) 
Acquired accounts receivable  $92,585      
Property, plant and equipment   8,593    7 
Right-of-use asset   122,984      
Trade names   22,000    4 
Customer relationships   550,000    10 
Agency relationships   2,585,000    10 
Developed technology   230,000    5 
Lease liability   (122,984)     
Goodwill   4,236,822    Indefinite 
   $7,725,000      
SCHEDULE OF PRO FORMA INFORMATION RELATED TO ACQUISITION

SCHEDULE OF PRO FORMA INFORMATION RELATED TO ACQUISITION

   June 30,   June 30, 
   2022   2021 
Revenue  $8,990,529   $5,364,335 
Net Income (Loss)  $20,070,124   $(1,527,038)
Earnings (Loss) per common share, basic  $11.40   $(2.40)
Earnings (Loss) per common share, diluted  $(8.70)  $(2.40)